• 1
    Chitsulo L, Loverde P & Engels D. Schistosomiasis. Nat Rev Microbiol 2004; 2: 1213.
  • 2
    Iarotski LS & Davis A. The schistosomiasis problem in the world: results of a WHO questionnaire survey. Bull World Health Organ 1981; 59: 115127.
  • 3
    Asher MI & Weiland SK. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steering Committee. Clin Exp Allergy 1998; 28 (Suppl. 5): 5266; discussion 90–91.
  • 4
    Bochner BS, Undem BJ & Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol 1994; 12: 295335.
  • 5
    Teran LM. Chemokines and IL-5: major players of eosinophil recruitment in asthma. Clin Exp Allergy 1999; 29: 287290.
  • 6
    Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C & Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 1998; 101: 21292139.
  • 7
    Postlethwaite AE, Holness MA, Katai H & Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992; 90: 14791485.
  • 8
    Kay AB. T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol 1991; 94: 189193.
  • 9
    La Flamme AC, Ruddenklau K & Backstrom BT. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003; 71: 49965004.
  • 10
    Sabin EA, Araujo MI, Carvalho EM & Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 1996; 173: 269272.
  • 11
    Araujo MI, Lopes AA, Medeiros M et al. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 2000; 123: 145148.
  • 12
    Van Den Biggelaar AH, Van Ree R, Rodrigues LC et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356: 17231727.
  • 13
    Medeiros M Jr, Figueiredo JP, Almeida MC et al. Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol 2003; 111: 947951.
  • 14
    Sears MR. Descriptive epidemiology of asthma. Lancet 1997; 350 (Suppl. 2): SII1-4.
  • 15
    Sears MR. Evolution of asthma through childhood. Clin Exp Allergy 1998; 28 (Suppl. 5): 8289; discussion 90–91.
  • 16
    Pearce N, Sunyer J, Cheng S et al. Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J 2000; 16: 420426.
  • 17
    Aberg N, Hesselmar B, Aberg B & Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995; 25: 815819.
  • 18
    Von Mutius E. The rising trends in asthma and allergic disease. Clin Exp Allergy 1998; 28 (Suppl. 5): 4549; discussion 50–51.
  • 19
    Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E & Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997; 350: 8590.
  • 20
    Araujo MI, Hoppe B, Medeiros M Jr et al. Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J Infect Dis 2004; 190: 17971803.
  • 21
    Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 12591260.
  • 22
    Jarrett EE & Kerr JW. Threadworms and IgE in allergic asthma. Clin Allergy 1973; 3: 203207.
  • 23
    Carswell F, Meakins RH & Harland PS. Parasites and asthma in Tanzanian children. Lancet 1976; 2: 706707.
  • 24
    Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R & Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 1993; 92: 404411.
  • 25
    Van Den Biggelaar AH, Borrmann S, Kremsner P & Yazdanbakhsh M. Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses. J Infect Dis 2002; 186: 14741482.
  • 26
    Cooper PJ, Chico ME, Rodrigues LC et al. Risk factors for atopy among school children in a rural area of Latin America. Clin Exp Allergy 2004; 34: 845852.
  • 27
    Hagel I, Lynch NR, DiPrisco MC, Lopez RI & Garcia NM. Allergic reactivity of children of different socioeconomic levels in tropical populations. Int Arch Allergy Immunol 1993; 101: 209214.
  • 28
    Cooper PJ, Chico ME, Rodrigues LC et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 2003; 111: 9951000.
  • 29
    Van Den Biggelaar AH, Lopuhaa C, Van Ree R et al. The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol 2001; 126: 231238.
  • 30
    Kayhan B, Telatar H & Karacadag S. Bronchial asthma associated with intestinal parasites. Am J Gastroent 1978; 69: 605606.
  • 31
    Guement JM. [Bronchial asthma, spasmodic coryza and parasitic diseases]. Nouv Presse Med 1973; 2: 2125.
  • 32
    Palmer LJ, Celedon JC, Weiss ST, Wang B, Fang Z & Xu X. Ascaris lumbricoides infection is associated with increased risk of childhood asthma and atopy in rural China. Am J Respir Crit Care Med 2002; 165: 14891493.
  • 33
    Ponte E, Lima F, Araujo MI, Oliveira RR, Cardoso LS & Cruz AA. Skin test reactivity and Der p1-induced IL-10 production in patients with asthma or rhinitis infected with Ascaris. Ann Allergy Asthma Immunol 2006; 96: 713718.
  • 34
    Lynch NR, Lopez RI, Di Prisco-Fuenmayor MC et al. Allergic reactivity and socio-economic level in a tropical environment. Clin Allergy 1987; 17: 199207.
  • 35
    Finkelman FD, Shea-Donohue T, Goldhill J et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol 1997; 15: 505533.
  • 36
    Mota-Santos TA, Oliveira AF, Gerken SE & Vaz NM. Anaphylaxis with Schistosoma mansoni extracts in normal and infected mice. Rev Inst Med Trop Sao Paulo 1985; 27: 179185.
  • 37
    Pincus SH, Butterworth AE, David JR, Robbins M & Vadas MA. Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: lack of requirement for oxidative metabolism. J Immunol 1981; 126: 17941799.
  • 38
    Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A & Dessein AJ. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993; 168: 10001008.
  • 39
    Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583594.
  • 40
    Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD & Wynn TA. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 2001; 34: 273282.
  • 41
    De Jesus AR, Magalhaes A, Miranda DG et al. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 2004; 72: 33913397.
  • 42
    Correa-Oliveira R, Malaquias LC, Falcao PL et al. Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz J Med Biol Res 1998; 31: 171177.
  • 43
    Zouain CS, Falcao PL, Goes TS, Leite MF & Goes AM. Schistosoma mansoni PIII antigen modulates in vitro granuloma formation by regulating CD28, CTLA-4, and CD86 expression in humans. Immunol Lett 2004; 91: 113118.
  • 44
    Falcao PL, Malaquias LC, Martins-Filho OA et al. Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol 1998; 20: 447454.
  • 45
    Carneiro-Santos P, Martins-Filho O, Alves-Oliveira LF et al. Apoptosis: a mechanism of immunoregulation during human Schistosomiasis mansoni. Parasite Immunol 2000; 22: 267277.
  • 46
    Booth M, Mwatha JK, Joseph S et al. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol 2004; 172: 12951303.
  • 47
    Araujo MI, De Jesus AR, Bacellar O, Sabin E, Pearce E & Carvalho EM. Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol 1996; 26: 13991403.
  • 48
    Porto AF, Santos SB, Alcantara L et al. HTLV-1 modifies the clinical and immunological response to schistosomiasis. Clin Exp Immunol 2004; 137: 424429.
  • 49
    Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Med Inflamm 2001; 10: 5159.
  • 50
    Ramalingam TR, Reiman RM & Wynn TA. Exploiting worm and allergy models to understand Th2 cytokine biology. Curr Opin Allergy Clin Immunol 2005; 5: 392398.
  • 51
    Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R & Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353360.
  • 52
    Mosmann TR, Cherwinski H, Bond MW, Giedlin MA & Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 23482357.
  • 53
    Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S & Rudin A. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34: 13641372.
  • 54
    Pearce EJ & MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499511.
  • 55
    De Jesus AR, Silva A, Santana LB et al. Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis 2002; 185: 98105.
  • 56
    Montenegro SM, Miranda P, Mahanty S et al. Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens. J Infect Dis 1999; 179: 15021514.
  • 57
    Pearce EJ, Caspar P, Grzych JM, Lewis FA & Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 1991; 173: 159166.
  • 58
    Schmitz J, Thiel A, Kuhn R et al. Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells. J Exp Med 1994; 179: 13491353.
  • 59
    Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG & Foster PS. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 1998; 161: 15011509.
  • 60
    Li J, Scott P & Farrell JP. In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis. Infect Immun 1996; 64: 52485254.
  • 61
    Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS & Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990; 171: 115127.
  • 62
    Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G & Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol 1995; 154: 53205330.
  • 63
    Patton EA, Brunet LR, La Flamme AC, Pedras-Vasconcelos J, Kopf M & Pearce EJ. Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independent. Infect Immun 2001; 69: 589592.
  • 64
    Ghaemmaghami AM, Gough L, Sewell HF & Shakib F. The proteolytic activity of the major dust mite allergen Der p 1 conditions dendritic cells to produce less interleukin-12: allergen-induced Th2 bias determined at the dendritic cell level. Clin Exp Allergy 2002; 32: 14681475.
  • 65
    Traidl-Hoffmann C, Mariani V, Hochrein H et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005; 201: 627636.
  • 66
    Barton GM & Medzhitov R. Toll-like receptor signaling pathways. Science 2003; 300: 15241525.
  • 67
    McGreal EP, Miller JL & Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr Opin Immunol 2005; 17: 1824.
  • 68
    MacDonald AS, Straw AD, Bauman B & Pearce EJ. CD8– dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001; 167: 19821988.
  • 69
    Kane CM, Cervi L, Sun J et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 2004; 173: 74547461.
  • 70
    Donnelly S, Dalton JP & Loukas A. Proteases in helminth- and allergen-induced inflammatory responses. Chem Immunol Allergy 2006; 90: 4564.
  • 71
    Silveira MR, Nunes KP, Cara DC et al. Infection with Strongyloides venezuelensis induces transient airway eosinophilic inflammation, an increase in immunoglobulin E, and hyperresponsiveness in rats. Infect Immun 2002; 70: 62636272.
  • 72
    Dagoye D, Bekele Z, Woldemichael K et al. Wheezing, allergy, and parasite infection in children in urban and rural Ethiopia. Am J Respir Crit Care Med 2003; 167: 13691373.
  • 73
    Yazdanbakhsh M, Kremsner PG & Van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 490494.
  • 74
    Arruda LK & Santos AB. Immunologic responses to common antigens in helminthic infections and allergic disease. Curr Opin Allergy Clin Immunol 2005; 5: 399402.
  • 75
    Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J & Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97: 12881296.
  • 76
    Macedo MS, Faquim-Mauro E, Ferreira AP & Abrahamsohn IA. Immunomodulation induced by Ascaris suum extract in mice: effect of anti-interleukin-4 and anti-interleukin-10 antibodies. Scand J Immunol 1998; 47: 1018.
  • 77
    Cooper PJ. Can intestinal helminth infections (geohelminths) affect the development and expression of asthma and allergic disease? Clin Exp Immunol 2002; 128: 398404.
  • 78
    Lynch NR, Hagel IA, Palenque ME et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998; 101: 217221.
  • 79
    Terrazas LI, Walsh KL, Piskorska D, McGuire E & Harn DA Jr. The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections. J Immunol 2001; 167: 52945303.
  • 80
    Velupillai P, Dos Reis EA, Dos Reis MG & Harn DA. Lewis(x)-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis. Hum Immunol 2000; 61: 225232.
  • 81
    Van Den Biggelaar AH, Rodrigues LC, Van Ree R et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 2004; 189: 892900.
  • 82
    Williams ME, Montenegro S, Domingues AL et al. Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens. J Infect Dis 1994; 170: 946954.
  • 83
    Fowler S & Powrie F. Control of immune pathology by IL-10-secreting regulatory T cells. Springer Semin Immunopathol 1999; 21: 287294.
  • 84
    Royer B, Varadaradjalou S, Saas P, Guillosson JJ, Kantelip JP & Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy 2001; 31: 694704.
  • 85
    Medeiros M Jr, Almeida MC, Figueiredo JP et al. Low frequency of positive skin tests in asthmatic patients infected with Schistosoma mansoni exposed to high levels of mite allergens. Pediatr Allergy Immunol 2004; 15: 142147.
  • 86
    Lu FM, Chou CC, Chiang BL & Hsieh KH. Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels. Ann Allergy Asthma Immunol 1998; 80: 419423.
  • 87
    Akdis M, Blaser K & Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116: 961968; quiz 9.
  • 88
    Scrivener S, Yemaneberhan H, Zebenigus M et al. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 2001; 358: 14931499.
  • 89
    Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737742.
  • 90
    Inobe JI, Chen Y & Weiner HL. In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1996; 778: 390392.
  • 91
    Hansen G, McIntire JJ, Yeung VP et al. CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000; 105: 6170.
  • 92
    Oh JW, Seroogy CM, Meyer EH et al. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 2002; 110: 460468.
  • 93
    Jutel M, Akdis M, Budak F et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 12051214.
  • 94
    Bellinghausen I, Klostermann B, Knop J & Saloga J. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 2003; 111: 862868.
  • 95
    Elliott DE, Li J, Blum A et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003; 284: G385G391.
  • 96
    Taylor A, Verhagen J, Akdis CA & Akdis M. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int Arch Allergy Immunol 2004; 135: 7382.
  • 97
    McKee AS & Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 12241231.
  • 98
    Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr & Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004; 34: 26902698.
  • 99
    Wohlleben G, Trujillo C, Muller J et al. Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 2004; 16: 585596.
  • 100
    Akbari O, Stock P, Meyer E et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9: 582588.
  • 101
    Zaccone P, Fehervari Z, Jones FM et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003; 33: 14391449.
  • 102
    Fiorentino DF, Bond MW & Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 20812095.